Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Systematic Review and Involvement of Low and Middle Income Countries

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Feb 14

PMID 29438429

Citations 34

Authors

Katherine Davis

Sarah L Gorst

Nicola Harman

Valerie Smith

Elizabeth Gargon

Douglas G Altman

Jane M Blazeby

Mike Clarke

Sean Tunis

Paula R Williamson

Affiliations

Soon will be listed here.

Abstract

Background: Core outcome sets (COS) comprise a minimum set of outcomes that should be measured and reported in all trials for a specific health condition. The COMET (Core Outcome Measures in Effectiveness Trials) Initiative maintains an up to date, publicly accessible online database of published and ongoing COS. An annual systematic review update is an important part of this process.

Methods: This review employed the same, multifaceted approach that was used in the original review and the previous two updates. This approach has identified studies that sought to determine which outcomes/domains to measure in clinical trials of a specific condition. This update includes an analysis of the inclusion of participants from low and middle income countries (LMICs) as identified by the OECD, in these COS.

Results: Eighteen publications, relating to 15 new studies describing the development of 15 COS, were eligible for inclusion in the review. Results show an increase in the use of mixed methods, including Delphi surveys. Clinical experts remain the most common stakeholder group involved. Overall, only 16% of the 259 COS studies published up to the end of 2016 have included participants from LMICs.

Conclusion: This review highlights opportunities for greater public participation in COS development and the involvement of stakeholders from a wider range of geographical settings, in particular LMICs.

Citing Articles

Methodology for the selection and evaluation of outcomes for Chinese herbal injection in acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a comprehensive study.

Kong D, Yang S, Zhao H, Hao X, Zhang T, Lu Y Ann Med. 2024; 56(1):2396567.

PMID: 39253851 PMC: 11389646. DOI: 10.1080/07853890.2024.2396567.

Core outcome sets for trials of interventions to prevent and to treat multimorbidity in adults in low and middle-income countries: the COSMOS study.

Vidyasagaran A, Ayesha R, Boehnke J, Kirkham J, Rose L, Hurst J BMJ Glob Health. 2024; 9(8).

PMID: 39160083 PMC: 11340216. DOI: 10.1136/bmjgh-2024-015120.

Laparoscopic cholecystectomy versus conservative management for adults with uncomplicated symptomatic gallstones: the C-GALL RCT.

Innes K, Ahmed I, Hudson J, Hernandez R, Gillies K, Bruce R Health Technol Assess. 2024; 28(26):1-151.

PMID: 38943314 PMC: 11228691. DOI: 10.3310/MNBY3104.

Experiences of core outcome set developers on including stakeholders from low- and middle-income countries: An online survey.

Karumbi J, Gorst S, Gathara D, Young B, Williamson P PLOS Glob Public Health. 2024; 4(6):e0003365.

PMID: 38900810 PMC: 11189180. DOI: 10.1371/journal.pgph.0003365.

Core outcome sets for trials of interventions to prevent and to treat multimorbidity in low- and middle-income countries: the COSMOS study.

Vidyasagaran A, Ayesha R, Boehnke J, Kirkham J, Rose L, Hurst J medRxiv. 2024; .

PMID: 38352562 PMC: 10863036. DOI: 10.1101/2024.01.29.24301589.

References

Khanna D, Mittoo S, Aggarwal R, Proudman S, Dalbeth N, Matteson E . Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group. J Rheumatol. 2015; 42(11):2168-71. PMC: 4809413. DOI: 10.3899/jrheum.141182. View

Deyo R, Dworkin S, Amtmann D, Andersson G, Borenstein D, Carragee E . Report of the NIH Task Force on research standards for chronic low back pain. J Pain. 2014; 15(6):569-85. PMC: 4128347. DOI: 10.1016/j.jpain.2014.03.005. View

Kirkham J, Boers M, Tugwell P, Clarke M, Williamson P . Outcome measures in rheumatoid arthritis randomised trials over the last 50 years. Trials. 2013; 14:324. PMC: 3852710. DOI: 10.1186/1745-6215-14-324. View

Billings 4th F, Shaw A . Clinical trial endpoints in acute kidney injury. Nephron Clin Pract. 2014; 127(1-4):89-93. PMC: 4480222. DOI: 10.1159/000363725. View

Williamson P, Altman D, Blazeby J, Clarke M, Devane D, Gargon E . Developing core outcome sets for clinical trials: issues to consider. Trials. 2012; 13:132. PMC: 3472231. DOI: 10.1186/1745-6215-13-132. View

Coolsen M, Clermonts S, M van Dam R, Winkens B, Malago M, Fusai G . Development of a composite endpoint for randomized controlled trials in pancreaticoduodenectomy. World J Surg. 2013; 38(6):1468-75. DOI: 10.1007/s00268-013-2421-y. View

Fong F, Rogozinska E, Allotey J, Kempley S, Shah D, Thangaratinam S . Development of maternal and neonatal composite outcomes for trials evaluating management of late-onset pre-eclampsia. Hypertens Pregnancy. 2013; 33(2):115-31. DOI: 10.3109/10641955.2013.837176. View

Gerritsen A, Jacobs M, Henselmans I, van Hattum J, Efficace F, Creemers G . Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey. Eur J Cancer. 2016; 57:68-77. DOI: 10.1016/j.ejca.2016.01.001. View

Williamson P, Altman D, Bagley H, Barnes K, Blazeby J, Brookes S . The COMET Handbook: version 1.0. Trials. 2017; 18(Suppl 3):280. PMC: 5499094. DOI: 10.1186/s13063-017-1978-4. View

10.

Myatt L, Redman C, Staff A, Hansson S, Wilson M, Laivuori H . Strategy for standardization of preeclampsia research study design. Hypertension. 2014; 63(6):1293-301. DOI: 10.1161/HYPERTENSIONAHA.113.02664. View

11.

Gorst S, Gargon E, Clarke M, Smith V, Williamson P . Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and Identification of Gaps. PLoS One. 2016; 11(12):e0168403. PMC: 5156438. DOI: 10.1371/journal.pone.0168403. View

12.

Macleod M, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis J . Biomedical research: increasing value, reducing waste. Lancet. 2014; 383(9912):101-4. DOI: 10.1016/S0140-6736(13)62329-6. View

13.

Gargon E, Gurung B, Medley N, Altman D, Blazeby J, Clarke M . Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One. 2014; 9(6):e99111. PMC: 4059640. DOI: 10.1371/journal.pone.0099111. View

14.

Gorst S, Gargon E, Clarke M, Blazeby J, Altman D, Williamson P . Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey. PLoS One. 2016; 11(1):e0146444. PMC: 4718543. DOI: 10.1371/journal.pone.0146444. View

15.

H Al Wattar B, Tamilselvan K, Khan R, Kelso A, Sinha A, Pirie A . Development of a core outcome set for epilepsy in pregnancy (E-CORE): a national multi-stakeholder modified Delphi consensus study. BJOG. 2016; 124(4):661-667. DOI: 10.1111/1471-0528.14430. View

16.

Sox H, Greenfield S . Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. 2009; 151(3):203-5. DOI: 10.7326/0003-4819-151-3-200908040-00125. View

17.

Orbai A, de Wit M, Mease P, Shea J, Gossec L, Leung Y . International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2016; 76(4):673-680. PMC: 5344772. DOI: 10.1136/annrheumdis-2016-210242. View

18.

Kirkham J, Gorst S, Altman D, Blazeby J, Clarke M, Devane D . Core Outcome Set-STAndards for Reporting: The COS-STAR Statement. PLoS Med. 2016; 13(10):e1002148. PMC: 5068732. DOI: 10.1371/journal.pmed.1002148. View

19.

Milman N, Boonen A, Tugwell P, Merkel P . Clinicians' perspective on key domains in ANCA-associated vasculitis: a Delphi exercise. Scand J Rheumatol. 2016; 46(2):112-117. PMC: 6546289. DOI: 10.1080/03009742.2016.1188980. View

20.

Chalmers I, Glasziou P . Avoidable waste in the production and reporting of research evidence. Lancet. 2009; 374(9683):86-9. DOI: 10.1016/S0140-6736(09)60329-9. View